MENU

Can PhenixFIN (PFX) Stock Reach $60?

a closed-end investment trust

PFX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Oct 28, 2026

Can PhenixFIN (PFX) Stock Reach $60?

Key Takeaways

  • The $60 figure is not an analyst consensus; it is a fallback objective drawn from public discussion, principally Simply Wall St's discounted-cash-flow "future cash flow value" near $59.70 and its fair-value estimate near $63.40.
  • PhenixFIN Corporation (PFX) is an internally managed business development company (BDC), not an ETF, and trades around $41, meaning the $60 target implies a roughly 46% rise — a very large move.
  • The stock trades at a deep discount to its net asset value (NAV) of about $79.56 per share (roughly 0.5x book), the central valuation argument behind the higher public targets.
  • Verifiable sell-side coverage is effectively nonexistent: aggregators show only one, stale target of $10.00 — far below the current price — so it cannot support a meaningful consensus.
  • Supporting factors include heavy share buybacks, sustained insider buying by the CEO, and a lean internally managed cost structure.
  • Principal risks include weak return on equity, limited liquidity, leverage, concentrated equity exposure, and a shallow analyst/investor following.
  • For more on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore these pages for additional context.
  • Explore Trending AI Robots for AI-driven screening and monitoring ideas.

Analyst Price Targets and Consensus View

PhenixFIN Corporation (PFX) has essentially no usable analyst price-target coverage. Data aggregators list only a single, clearly stale target of $10.00, which sits far below the current share price and cannot be treated as a credible estimate. Because a reliable multi-analyst consensus cannot be assembled, the $60 objective used here is a fallback built from identifiable public discussion rather than any official consensus.

Specifically, Simply Wall St's discounted-cash-flow model produces a "future cash flow value" of roughly $59.70 and a fair-value estimate near $63.40 (it frames the shares as roughly 26% undervalued). Separately, a Seeking Alpha analysis highlighted "potential 30% upside" based on earnings before hidden tax assets, while repeatedly citing the stock's discount to book value. The $60 figure is a clean, reader-friendly representation of that cluster of public valuation commentary, not a published analyst target.

Current Market Position and Path Toward the Target

As of late October 2026, PFX traded near $41, within a 52-week range of $38.30 to $56.48. Reaching $60 would require a gain of roughly 46% from that level — a very large move for a micro-cap with a market capitalization around $80 million and average daily volume in the low thousands of shares.

The clearest path implied by public commentary is a narrowing of the gap between the share price and NAV per share, which stood at about $79.56 at the end of the March 2026 quarter. If investors were to re-rate the stock from roughly 0.5x book toward a more conventional BDC multiple, a move toward $60 becomes arithmetically plausible — but that re-rating depends on sustained net investment income, disciplined capital returns, and greater investor confidence in a portfolio weighted toward equity and warrants.

What Could Support a Move Toward the Target

  • Deep discount to NAV. Trading near half of book value gives the shares substantial re-rating headroom if portfolio marks hold up.
  • Aggressive buybacks. The company repurchased roughly 787,000 shares (about 29% of shares outstanding) since 2021 at an average price near $40.94, shrinking the share count.
  • Insider buying. Chairman and CEO David Lorber has been a consistent buyer, adding roughly $1.7 million over a recent three-month stretch.
  • Lean cost structure. As an internally managed BDC, PhenixFIN avoids external management fees, which can support net investment income.

What Could Prevent the Target From Being Reached

  • Weak profitability. Return on equity of only about 3% and negative trailing net income suggest the discount may partly reflect fundamentals rather than pure opportunity.
  • Leverage. Roughly $147 million in borrowings at a weighted average rate near 5.9% magnify losses if portfolio values decline.
  • Equity-heavy, concentrated portfolio. Equity and warrants are the largest portfolio bucket, and the book is concentrated in a handful of controlled and affiliated positions.
  • Illiquidity and thin coverage. Very low trading volume and minimal analyst following can keep the discount entrenched.

Technical Levels and Market Structure

The 52-week high near $56.48, reached in August 2026, is the nearest major prior high below the $60 objective. The $38.30–$38.75 area has acted as a durable support level, while the stock has repeatedly struggled to hold above the mid-$40s. A sustained close above the $50 psychological zone would be the first structural step needed before $60 comes into view.

Time Horizon and What Investors Should Monitor

Analyst price targets, where they exist, typically reflect a 12-month horizon, but no meaningful such target exists for PFX. Investors should watch quarterly net asset value and net investment income, the fiscal 2026 earnings release scheduled around December 11, 2026, further buyback activity, insider transactions, and any change in the board-approved plan to reduce the asset-coverage requirement from 200% to 150% (effective May 2027). Portfolio-company performance and credit quality across the equity-heavy book remain the key swing factors.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a thinly traded security such as PFX, these signals can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening. Explore the signals to see how the model is currently reading the stock's technical and market structure.

Final Assessment

The $60 objective for PhenixFIN Corporation (PFX) rests on public valuation commentary — chiefly a discounted-cash-flow "future cash flow value" near $59.70 and a fair-value estimate near $63.40 — rather than any analyst consensus, which is unavailable for this micro-cap BDC. From a share price near $41, the move would be very large at roughly 46%. The strongest support is the deep discount to NAV of about $79.56 per share, reinforced by aggressive buybacks and insider buying; the principal obstacles are weak return on equity, leverage, an equity-heavy portfolio, and extremely thin liquidity. Whether the gap closes depends on sustained NAV stability and investor conviction, neither of which is guaranteed. Investors should monitor quarterly NAV, earnings, buyback and insider activity, and the evolving discount to book before drawing conclusions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
PFX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PFX and Stocks

Correlation & Price change

A.I.dvisor tells us that PFX and SLRC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PFX and SLRC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFX
1D Price
Change %
PFX100%
+0.27%
SLRC - PFX
23%
Poorly correlated
+1.55%
TPG - PFX
22%
Poorly correlated
+3.21%
FSK - PFX
21%
Poorly correlated
+3.72%
OFS - PFX
21%
Poorly correlated
+0.28%
SAR - PFX
21%
Poorly correlated
+0.07%
More